Consortium Pharmaceutique de Belgique SA
2.4 FTEConsortium Pharmaceutique de Belgique reported total assets of €1.35m at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026), with 2.4 full-time equivalents.
By total assets for 2025, Consortium Pharmaceutique de Belgique ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Consortium Pharmaceutique de Belgique shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +102 % Total assets +26 % Headcount (avg FTE) -38 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Consortium Pharmaceutique de Belgique's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 70,413 € | ||||
| Equity | 340,056 € | ||||
| Cash | 265,028 € | ||||
| EBITDA | 150,362 € | ||||
| Total assets | €1.35m |
Filed annual accounts
- Year ended 30 Sep 2025filed on 16 Jul 2026
- Year ended 30 Sep 2024filed on 06 May 2025
- Year ended 30 Sep 2023filed on 08 May 2024
- Year ended 30 Sep 2022filed on 03 May 2023
- Year ended 30 Sep 2021filed on 12 May 2022
Consortium Pharmaceutique de Belgique's financial analysis
- Solvency25.1%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Consortium Pharmaceutique de Belgique
4 active director(s) in the register.
Consortium Pharmaceutique de Belgique's shareholders and holdings →Consortium Pharmaceutique de Belgique's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0874.822.610
- VAT number
- BE0874822610
- Peppol
- Registered · 0208:0874822610 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Jul 2005
- Registered office
- 1180 Uccle
- Size
- Micro · 2.4 FTE
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Consortium Pharmaceutique de Belgique (SA) has been based in Uccle since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 70,413 € and equity of 340,056 €; its revenue is not published. With 2.4 full-time equivalents, it is a micro-enterprise by headcount.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Consortium Pharmaceutique de Belgique
Companies in the same business, of comparable size and area, outside its group.
- A.D.T. Belgium Retail sale of medical and orthopaedic goods Beersel · balance sheet €1.31m
- Apotheek de Preter A. Retail sale of pharmaceutical products Sint-Niklaas · balance sheet €1.26m
- La Boverie Retail sale of pharmaceutical products Namur · balance sheet €1.89m
- Pharmacie Melon Retail sale of pharmaceutical products Fontaine-l'Évêque · balance sheet 581,816 €
- Arterix Retail sale of medical and orthopaedic goods Destelbergen · balance sheet 9,206 €
- Ortho Sina Wholesale of pharmaceutical and medical goods Jette · balance sheet €1.41m
- AUXILIAIRE ACOUSTIQUE DE CHARLEROI (Ets VERANNEMAN Retail sale of medical and orthopaedic goods Charleroi · balance sheet €1.33m
- Impact Wholesale of pharmaceutical and medical goods Chaudfontaine · balance sheet €1.44m
Frequently asked questions about Consortium Pharmaceutique de Belgique
What is the revenue of Consortium Pharmaceutique de Belgique?
Consortium Pharmaceutique de Belgique files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Consortium Pharmaceutique de Belgique?
In Belgium, the VAT number is the company number prefixed with BE: BE0874822610 for Consortium Pharmaceutique de Belgique, if the company is VAT-registered. Its company number (CBE) is 0874.822.610.
Where is the registered office of Consortium Pharmaceutique de Belgique?
According to the CBE register, the registered office of Consortium Pharmaceutique de Belgique is in 1180 Uccle.
What is the equity of Consortium Pharmaceutique de Belgique?
At the close of the 2025 financial year, the equity of Consortium Pharmaceutique de Belgique amounts to 340,056 €, a solvency of 25.1% of total assets.
How many people work at Consortium Pharmaceutique de Belgique?
2.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Consortium Pharmaceutique de Belgique?
The register lists 4 active mandates at Consortium Pharmaceutique de Belgique. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Consortium Pharmaceutique de Belgique within its sector?
By total assets for 2025, Consortium Pharmaceutique de Belgique ranks among the 1,000 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.
The full file of Consortium Pharmaceutique de Belgique
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →